retatrutide triple hormone receptor agonist metabolic obesity glp-1 gip glucagon phase 2 nejm 2023 Medscape Retatrutide for weight loss: Study

Ginkgotoxin is found in the ginkgo leaf at very low amounts

GLP-1 receptor agonists like semaglutide can still be effective for weight loss in post-thyroidectomy patients, but the absence of a functional thyroid creates distinct considerations that require informed medical oversight

It is also possible that riboflavin exerts its antioxidant effect by reinforcing the effect of other antioxidants such as vitamin C ( Reference Rao and Bhat 29 )

The most common adverse event was dose-dependent, transient, mild-to-moderate nausea

Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon Receptor TriagonistObesity, NAFLD, and T2D Phase 2 Trial Results In this medfyle Two phase II studies showed that the triple agonist retatrutide is associated with significant weight loss in obese patients and substantial improvement in glycemia control and significant weight loss in patients with T2D

This data from rodent studies has led to GLP-1RAs being contraindicated in patients with a personal or family history of MTC or with multiple endocrine neoplasia syndrome type 2